5 Healthcare Stocks to Buy Now According to Billionaire Larry Robbins

3. Bausch Health Companies (NYSE:BHC)

Glenview Capital’s Stake Value: $211.5 million

Percentage of Glenview Capital’s 13F Portfolio: 4.28%

Number of Hedge Fund Holders: 48

Bausch Health Companies (NYSE:BHC) is a Canadian pharmaceutical company, primarily focusing on skin diseases, gastrointestinal disorders, eye health, and neurology. The company has close to 20,000 employees.

Bausch Health Companies (NYSE:BHC) was a part of 48 hedge fund portfolios in the first quarter of 2022 with a combined stake value of $3.17 billion, compared to 53 portfolios with stakes worth $3.865 billion in the previous quarter. Bausch Health Companies (NYSE:BHC) covered 4.28% of Glenview Capital’s portfolio with 9.256 million shares worth $211.5 million.

On June 13, JPMorgan analyst Chris Schott initiated Bausch Health Companies (NYSE:BHC)’s coverage with an Overweight rating and a $12 price target. The analyst noted that the Xifaxan patent litigation and Bausch & Lomb separation pathway significantly affects the stock’s valuation.